Familial breast cancer report

Familial breast cancer report 

The updated NICE guideline 164 on familial breast cancer was published in June 2013 offering several evidence-based recommendations in areas including genetic testing, surveillance and treatment strategies.

Although NICE guidelines have no formal status in Scotland, they are considered by NHSScotland in the absence of Scottish guidance from the Scottish Intercollegiate Guidelines Network (SIGN).

A short life working group (SLWG), under the Chairmanship of Dr Hilary Dobson, Clinical Lead West of Scotland Cancer Network, was formed to address the applicability of the recommendations from the NICE guideline for the Scottish population and consider and identify any implementation challenges posed. Membership of the group included representation from the three Scottish cancer networks and lay representation. The group was supported by Healthcare Improvement Scotland.

This report identifies the recommendations that should be prioritised for implementation in NHSScotland and identifies barriers for implementation of those recommendations and the resources or processes required to overcome these.

Published Date: 10 June 2014